Literature DB >> 14552571

The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis.

M Morosini1, F Meloni, A Marone Bianco, E Paschetto, M Uccelli, E Pozzi, A Fietta.   

Abstract

OBJECTIVES: To assess the role of IFN-gamma and its regulatory cytokines in active pulmonary tuberculosis (TB).
DESIGN: Cytokines were measured in the plasma of TB patients and healthy subjects with different risk for TB exposure. In addition, cytokine profile was assessed in the bronchoalveolar lavage fluid (BALf) of six TB patients and nine normal controls.
RESULTS: Circulating IFN-gamma, IL-10 and IL-18 were higher in TB patients than in control groups. Plasma IL-12 levels were extremely variable, and no difference was observed among study groups. An inverse correlation between plasma IFN-gamma and IL-10 levels was found in TB patients. Furthermore, circulating IL-18 correlated with IL-10 but not with IFN-gamma levels. Finally, IFN-gamma, IL-18 and IL-12 were increased in the BALf of TB patients, whereas no difference was observed in IL-10 levels.
CONCLUSIONS: In human TB, at least at certain disease stages, there is a differential compartmentalization of the IFN-gamma-regulatory factors IL-12 and IL-10, the former being concentrated in the lungs and the latter being present in peripheral circulation. In addition, our findings address more critically the role of IL-18 in the host response to tuberculosis infection in humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14552571

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  13 in total

1.  Microarray analysis of Mycobacterium tuberculosis-infected monocytes reveals IL26 as a new candidate gene for tuberculosis susceptibility.

Authors:  José M Guerra-Laso; Sara Raposo-García; Silvia García-García; Cristina Diez-Tascón; Octavio M Rivero-Lezcano
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

2.  Compartmentalized bronchoalveolar IFN-gamma and IL-12 response in human pulmonary tuberculosis.

Authors:  Maria Teresa Herrera; Martha Torres; Denarra Nevels; Carlos Núñez Perez-Redondo; Jerrold J Ellner; Eduardo Sada; Stephan K Schwander
Journal:  Tuberculosis (Edinb)       Date:  2008-10-09       Impact factor: 3.131

3.  Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis.

Authors:  Zahra Hasan; Bushra Jamil; Mussarat Ashraf; Muniba Islam; Maqboola Dojki; Muhammad Irfan; Rabia Hussain
Journal:  Clin Vaccine Immunol       Date:  2009-05-13

4.  Molecular signatures distinguishing active from latent tuberculosis in peripheral blood mononuclear cells, after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD) or Candida: a preliminary report.

Authors:  Joel N H Stern; Derin B Keskin; Viviana Romero; Joaquin Zuniga; Liliana Encinales; Changlin Li; Carlos Awad; Edmond J Yunis
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

5.  Fluorescent cell barcoding as a tool to assess the age-related development of intracellular cytokine production in small amounts of blood from infants.

Authors:  Jose Stam; Wayel Abdulahad; Minke G Huitema; Caroline Roozendaal; Pieter C Limburg; Margriet van Stuijvenberg; Elisabeth H Schölvinck
Journal:  PLoS One       Date:  2011-10-17       Impact factor: 3.240

6.  DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis.

Authors:  Ludovic Tailleux; Nhan Pham-Thi; Anne Bergeron-Lafaurie; Jean-Louis Herrmann; Patricia Charles; Olivier Schwartz; Pierre Scheinmann; Philippe H Lagrange; Jacques de Blic; Abdellatif Tazi; Brigitte Gicquel; Olivier Neyrolles
Journal:  PLoS Med       Date:  2005-11-15       Impact factor: 11.069

7.  Changes in serum cytokine levels in active tuberculosis with treatment.

Authors:  Figen Deveci; H Handan Akbulut; Teyfik Turgut; M Hamdi Muz
Journal:  Mediators Inflamm       Date:  2005-10-24       Impact factor: 4.711

8.  Allergic sensitisation in tuberculosis patients at the time of diagnosis and following chemotherapy.

Authors:  Linda K Ellertsen; Dag G Storla; Lien M Diep; Karl A Brokstad; Harald G Wiker; Geir Hetland
Journal:  BMC Infect Dis       Date:  2009-06-26       Impact factor: 3.090

9.  Immune responses in the lungs of patients with tuberculous pleural effusion without pulmonary tuberculosis.

Authors:  Diana Qama; Won-Il Choi; Kun Young Kwon
Journal:  BMC Immunol       Date:  2012-08-13       Impact factor: 3.615

10.  Role of TNF-Alpha, IFN-Gamma, and IL-10 in the Development of Pulmonary Tuberculosis.

Authors:  Yone Vila Nova Cavalcanti; Maria Carolina Accioly Brelaz; Juliana Kelle de Andrade Lemoine Neves; José Candido Ferraz; Valéria Rêgo Alves Pereira
Journal:  Pulm Med       Date:  2012-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.